Abstract
Semaphorin 3A (SEMA3A), a secretory protein, is a founding member of the semaphorin family and functions in both the biological behavior of tumor cells and the modulation of tumor-associated macrophages. However, the role of SEMA3A in hepatocellular carcinoma (HCC) is still not well established. In the present study, we investigated the expression levels of SEMA3A in 80 HCC tissues and cell lines, using RT-qPCR, western blotting and immunohistochemistry. Expression profile analysis revealed that SEMA3A was significantly overexpressed in human HCC patients and positively correlated with the metastatic potential of HCC cells. Lentiviral transfection into PLC/PRF/5 and HCCLM3 cells was performed to stably upregulate and downregulate the expression of SEMA3A in HCC cells. Cell Counting Kit-8 (CCK-8), wound-healing and invasion assays revealed that SEMA3A promoted the proliferation and migration of HCC cells in vitro. Proteome profiler antibody microarray analysis revealed that overexpression of SEMA3A in HCC cells induced a significant increase in the expression levels of gelsolin-like capping protein (CapG), galectin-3, enolase 2 and epithelial cell adhesion molecule (EpCAM). Furthermore, the upregulation of SEMA3A in HCC cells pr...Continue Reading
References
Nov 1, 1992·Neuron·A L KolodkinC S Goodman
Dec 31, 1993·Cell·A L KolodkinC S Goodman
Apr 10, 1996·International Journal of Cancer. Journal International Du Cancer·F X SunZ C Ma
Oct 12, 2000·Mechanisms of Development·T ItoY Goshima
Mar 18, 2003·Nature Medicine·Qing-Hai YeXin Wei Wang
May 18, 2004·Journal of Cancer Research and Clinical Oncology·Yan LiZhao-You Tang
Apr 6, 2005·World Journal of Gastroenterology : WJG·Di-Peng OuZhi-Gang Chang
Apr 6, 2006·Genome Biology·Umar Yazdani, Jonathan R Terman
Feb 14, 2007·Seminars in Liver Disease·Augusto VillanuevaJosep M Llovet
Jul 17, 2007·International Journal of Cancer. Journal International Du Cancer·Michael W MüllerHelmut Friess
Dec 19, 2007·Nature Immunology·Kazuhiro SuzukiHitoshi Kikutani
Aug 18, 2009·Oncogene·T BagciD G Jay
Feb 12, 2010·Nature·Ruei-Jiun HungJonathan R Terman
Apr 14, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Olivier Gires, Patrick A Bauerle
Oct 16, 2010·The Prostate·V BlancM Williamson
Sep 1, 2011·Journal of Leukocyte Biology·Flavia GarciaWilson Savino
Jan 19, 2012·Science Signaling·Yuxiao WangXuewu Zhang
Apr 10, 2012·The Journal of Clinical Investigation·Federica MaioneEnrico Giraudo
Aug 7, 2012·Lancet·Roberto S OliveriChristian Gluud
Sep 3, 2013·Medical Oncology·Dongfang TangYi Shen
Dec 18, 2013·Cancer Cell·Lee B Rivera, Gabriele Bergers
Apr 26, 2014·Oncology Letters·Haiying ZhouZhiyong Zhang
Jun 26, 2014·The Journal of Pathology·Zhi DaiJia Fan
Feb 6, 2015·CA: a Cancer Journal for Clinicians·Lindsey A TorreAhmedin Jemal
Jan 14, 2016·Journal of the National Cancer Institute·Jules A WestbrookJanet E Brown
Jan 26, 2016·CA: a Cancer Journal for Clinicians·Wanqing ChenJie He
Feb 24, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Lei Wang, Xiu-Li Guo
Citations
Jan 31, 2019·International Journal of Molecular Sciences·Shira ToledanoGera Neufeld
Jun 21, 2019·Journal of Gastrointestinal Cancer·Tuba KarpuzMehmet Artac
Aug 5, 2020·The Journal of Clinical Investigation·Vincent Wai-Hin Yuen, Carmen Chak-Lui Wong
Nov 7, 2019·Pathology, Research and Practice·Zhiquan LangZhenhong Zou
Jul 15, 2021·Pathology Oncology Research : POR·Tímea KissMargit Balázs